Skip to main content

Advertisement

Table 2 Khorana Risk Score and Thrombosis Event Correlation. Fisher’s Exact test showed that there is no statistical VTE difference between AML patients with KRS 0 vs. KRS 1–3 (P = 0.2555). Also, a log-rank (Mantel-Cox) test showed no statistical difference of VTE risk between individual subgroups (P = 0.1949)

From: Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience

Khorana Score No. (%) of patients, n = 867 No. (%) of thrombosis events
0 191 (22) 6 (3)
1 445 (51) 23 (5)
2 207 (24) 13 (6.3)
3 24 (3) 0 (0)
1, 2, 3, and 4 (all patients) 867 (100) 42 (5)